Northwestern researchers have shown that when it comes to cancer vaccines, arrangement can be just as important as ingredients. By repositioning a small fragment of an HPV protein on a DNA-based ...
Researchers at UC San Francisco have uncovered a new clue to how Epstein-Barr virus (EBV) could contribute to multiple ...
The increased size of, and lesser blood supply to, a key brain structure in patients with Long COVID tracks with known blood ...
Study shows certain CD8+ immune cells are far more active in the nervous system of people with multiple sclerosis. Some ...
The data showed that a subset of killer T cells that also interact with EBV are more prevalent in people with the chronic autoimmune disease.
Morning Overview on MSN
NIH is testing a controversial COVID drug as a surprise cancer therapy
A non-NIH clinical trial is now testing ivermectin, the antiparasitic drug that became a lightning rod during the COVID-19 pandemic, as a potential weapon against one of the most aggressive forms of ...
A virus-agnostic nasal spray called ‘INNA-051’ was designed to increase innate immunity and prevent respiratory illnesses ...
Morning Overview on MSN
Leftover COVID-19 fragments found silently killing key immune cells
Long after the acute infection fades, pieces of the virus behind COVID-19 can linger in the body and quietly sabotage the ...
The National Cancer Institute, the federal research agency charged with leading the war against the nation's second-largest ...
Tech advances already show a future of testing in which we might not have to suffer and die while waiting for systems that don’t work.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results